Researchers have discovered a virus that could enter human cells in a similar way to COVID-19. But they caution it's much more poorly adapted to humans.

Lab experiments showed that the virus could infect human cells with high ACE2 levels, including models of human intestines ...

Tasmanians are expected to be able to access a Moderna Covid vaccine manufactured in Australia later this year.

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.

Persistent levels of spike protein from COVID-19 vaccines could be associated with a range of chronic symptoms like excessive ...

We’re in the heart of flu season, and it’s important to be mindful of how we choose to stay healthy. The CDC recommends ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna ...

The S&P 500 plunged by 1.7% on Friday, Feb. 21, as weak economic data and earnings forecasts sent the benchmark index lower for the second straight session.

A newly discovered bat coronavirus uses the same cell-surface protein to gain entry into human cells as the SARS-CoV-2 virus that causes COVID-19, raising the possibility that it could someday spread ...

CoV-2, has been discovered in China and is “strikingly similar to the pandemic virus” and feared to be powerful ...